DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Fizazi M. et al.
Longer term preplanned efficacy and safety analysis of abiraterone acetate + prednisone (AA + P) in patients (pts) with newly diagnosed high-risk metastatic castration-naïve prostate cancer (NDx-HR mCNPC) from the phase 3 LATITUDE trial.
J Clin Oncol 2018;
36 (Suppl. 15) 5023 (abstr)
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.